Pulmonary Atresia

Pulmonary atresia is a congenital heart defect present at birth in which blood flow from the heart to the lungs is severely impaired because the pulmonary valve has not formed adequately. When the pulmonary valve opening is closed or undeveloped, deoxygenated blood cannot reach the lungs through the normal route. For this reason, the condition becomes particularly important in the newborn period and may require urgent evaluation. ^[1][2][3]

This condition should not be confused with a “simple heart murmur” or temporary cyanosis. Signs may include bluish discoloration of the lips or skin, rapid breathing, tiring easily during feeding, and poor weight gain. In some infants, symptoms become apparent not immediately after birth but when a temporary blood vessel called the ductus arteriosus begins to close. Therefore, even a baby who appears normal in the first days of life may develop serious oxygen deficiency within a short time. ^[1][2][3]

What are the symptoms of pulmonary atresia?

Pulmonary atresia is often first noticed because of cyanosis in the newborn. The bluish discoloration results from low oxygen levels in the blood and may be visible around the mouth, on the lips, in the nail beds, or across the skin. In addition, rapid breathing, irritability, inability to continue sucking, sweating, lethargy, and tiring quickly while feeding may occur. The severity of the findings may vary depending on other structural heart abnormalities that accompany the condition. ^[1][2][3]

In some infants, development of the right ventricle may also be inadequate, making circulatory planning more complex. Associated openings or vascular connections may temporarily facilitate survival, but their natural course is not a permanent solution. Urgent pediatric cardiology evaluation is required if cyanosis worsens, the infant cannot feed, is difficult to arouse, or has marked respiratory distress. ^[1][2][4]

What causes it?

Pulmonary atresia develops while the fetal heart is forming during pregnancy. In most cases, the exact cause is unknown. As with congenital heart defects in general, genetic predisposition, certain syndromes, specific environmental exposures during pregnancy, or maternal medical conditions may be associated with risk; however, in most families no single clear cause is identified. For this reason, parents should not blame themselves. ^[1][3][4]

What matters here is not so much searching for a cause as rapidly assessing the infant’s circulatory needs. Pulmonary atresia is one of the critical congenital heart defects that becomes symptomatic as temporary fetal circulation pathways close after birth. Early diagnosis and care in the appropriate center can significantly affect survival and long-term outcomes. In cases suspected during pregnancy, it is important that delivery planning be carried out in experienced centers with the help of fetal echocardiography. ^[1][2][4]

How is it diagnosed?

Diagnosis may sometimes be made during pregnancy by ultrasound and fetal echocardiography, or it may be detected after birth during evaluation for cyanosis or low oxygen levels. Pulse oximetry screening in newborns may help identify low oxygen saturation, but echocardiography is the principal method for establishing a definite diagnosis. Echocardiography provides detailed assessment of valve structure, chamber size, and the direction of blood flow. ^[1][2][3]

When necessary, electrocardiography, chest X-ray, catheterization, and other advanced imaging methods may also be used. The goal is not only to confirm the diagnosis but also to map the anatomy of the heart and blood vessels in detail for treatment planning. Pulmonary atresia is not a single uniform disease; catheter-based intervention may be more suitable in some infants, whereas others require staged surgical management. ^[2][3][4]

How is treatment planned?

Because pulmonary atresia can be life-threatening, treatment often begins shortly after birth. The first goal is to ensure that enough blood reaches the lungs. Medications may be used to help keep the ductus arteriosus open. This temporary support is intended to stabilize the infant more safely until surgery or a catheter-based intervention can be performed. ^[1][2][3]

The next step may involve catheter-based enlargement of the valve opening, stent placement, creation of a shunt, or staged surgical procedures, depending on the infant’s anatomy. The size and function of the right ventricle are highly important in this planning. In some children, repair using both ventricles is the goal, whereas in others staged circulation strategies such as Glenn and Fontan procedures are considered. In rare cases, heart transplantation may also be discussed. ^[2][3]

Long-term follow-up and when emergency help is needed

Pulmonary atresia may not be a condition that is completely resolved with a single operation. As the child grows, the valve, blood vessels, heart rhythm, and cardiac function are reassessed. Some children may require repeat intervention, valve or vessel revision, rhythm monitoring, or assessment of exercise capacity. For this reason, pediatric cardiology follow-up should not be interrupted even after successful initial treatment. ^[1][2][4]

Emergency help is needed if cyanosis increases, the infant cannot feed, breathes rapidly, becomes excessively sleepy, develops fainting-like episodes, has cold feet, or shows marked weakness. Pulmonary atresia is a complex disease with anatomy that varies from one patient to another; treatment planning therefore cannot be based on internet information alone. The fundamental approach is joint evaluation by pediatric cardiology and cardiac surgery teams in an appropriate center. ^[1][2][3]

How does the follow-up process progress for families?

For an infant diagnosed with pulmonary atresia, the process does not end with hospital discharge. Feeding patterns at home, weight gain, the degree of cyanosis, respiratory rate, and regular medication use must all be monitored closely by the family. In some infants, the period until the next intervention may require weekly or even more frequent checkups. It is important for families to know the warning signs—such as worsening cyanosis, inability to continue sucking, excessive sleepiness, or rapid breathing—because this knowledge increases the chance of early intervention. ^[1][2][3]

In children living with pulmonary atresia, growth, development, exercise capacity, and resilience to infections are also assessed during follow-up. Some children do well for long periods, whereas others require additional interventions. Because of this variable course, it is safer for parents to adopt a structured follow-up mindset rather than thinking, “The first surgery is done, so everything is now completely fixed.” The next step is determined by evaluating medical visits, imaging results, and clinical findings together. ^[1][2][4]

FAQ

Is pulmonary atresia congenital?
Yes. Pulmonary atresia is present at birth and is therefore a congenital heart defect. ^[1][3]

What is the most common presenting sign?
Cyanosis in the newborn, rapid breathing, and difficulty feeding are among the most striking signs. ^[1][2]

Can it be diagnosed during pregnancy?
Yes. In some cases, diagnosis can be made by prenatal ultrasound and fetal echocardiography. ^[1][2]

Is treatment the same for every infant?
No. The treatment plan varies according to the valve structure, the development of the right ventricle, and accompanying vascular or cardiac differences. ^[2][3]

Why does follow-up take so long?
Because as the child grows, circulatory needs, valve structure, and the outcomes of previous interventions must all be reassessed. ^[1][4]